Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD Study of Emixustat in Geographic Atrophy
NCT02130531Phase 1Completed
- Sponsor
- Kubota Vision
- Start
- Apr 2014
- Primary completion
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of emixustat in geographic atrophy (GA) (2 cohorts), sponsored by Kubota Vision. Primary endpoints: Area Under the Concentration-Time Curve from time zero to 24 hours and Degree of suppression of the ERG b-wave response post-photobleaching. Started Apr 2014; status: completed.
02
Drugs
emixustat
03
Conditions
geographic atrophy (GA)
Beyond the preview
Go deeper on NCT02130531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02130531.